Table 1 COVID-19 ( +), Vaccination, and IFOPA- FOP Connection Registry Cohort Demographics
From: Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva
Characteristic | COVID-19 ( +) study subjects (N = 10) | Vaccination study subjects (N = 15) | FOP registry participants (N = 326) |
|---|---|---|---|
Current age (years) | |||
Mean | 31.2 | 31.2 | 26.1 |
Range | 17.0–46.0 | 13.0–51.0 | 1.4–76.0 |
Sex | |||
Male | 5 (50.0%) | 7 (46.7%) | 141 (43.3%) |
Female | 5 (50.0%) | 8 (53.3%) | 183 (56.1%) |
Other | Â | Â | 1 (0.3%) |
Missing | Â | Â | 1 (0.3%) |
Country/Region | |||
United States | 4 (40.0%) | 10 (66.7%) | 114 (35.0%) |
Brazil | Â | Â | 34 (10.4%) |
Europe | Â | Â | 30 (9.2%) |
United Kingdom | Â | 2 (13.3%) | 18 (5.5%) |
France | Â | Â | 15 (4.6%) |
Asia | Â | Â | 12 (3.7%) |
Spain | Â | Â | 12 (3.7%) |
Switzerland | Â | 1 (6.7%) | Â |
Serbia | 1 (10.0%) | Â | Â |
Italy | Â | Â | 11 (3.4%) |
Canada | Â | Â | 11 (3.4%) |
India | Â | Â | 10 (3.1%) |
Poland | Â | Â | 8 (2.5%) |
Africa | Â | Â | 7 (2.1%) |
Australia | Â | Â | 7 (2.1%) |
South America | Â | Â | 7 (2.1%) |
Russia | Â | Â | 6 (1.8%) |
Chile | Â | 1 (6.7%) | 5 (1.5%) |
Germany | Â | Â | 5 (1.5%) |
Colombia | Â | Â | 5 (1.5%) |
North America | Â | Â | 5 (1.5%) |
South Pacific Ocean | Â | Â | 3 (0.9%) |
Missing | 5 (50.0%) | 1 (6.7%) | 1 (0.3%) |